版本:
中国

BRIEF-Valeant receives lender consent for refinancing, amendment of credit agreement

March 10 Valeant Pharmaceuticals International Inc:

* Valeant receives lender consent for refinancing and amendment of credit agreement

* Valeant - obtained requisite lender approval for previously announced amendment of company's existing credit agreement

* Valeant - credit agreement amendment is expected to become effective concurrently with funding of new term b loans on or about March 21, 2017

* Valeant - obtained requisite lender approval for amendment of existing credit agreement to facilitate borrowing of new term b loans that mature in 2022 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐